Literature DB >> 26028000

Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis.

Koichiro Suemori1, Hitoshi Hasegawa, Jun Ishizaki, Takuya Matsumoto, Sachiko Onishi, Eiji Sada, Atsuro Sugita, Masaki Yasukawa.   

Abstract

Patients with rheumatoid arthritis (RA) treated with methotrexate (MTX) sometimes develop lymphoproliferative disease (LPD). MTX-associated LPD can affect nodal or extranodal sites, including the gastrointestinal tract, skin, lungs, kidneys and soft tissues, at almost equal frequency. However, it is very rare for MTX-associated LPD to manifest as multiple nodules in the lungs. We herein report the case of a RA patient who developed MTX-associated LPD with multiple pulmonary nodules during a 5-year course of MTX therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26028000     DOI: 10.2169/internalmedicine.54.3542

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  [Treatment of rheumatic diseases and pulmonary toxicity].

Authors:  J Schreiber; U Müller-Ladner
Journal:  Pneumologe (Berl)       Date:  2018-09-25

2.  Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis.

Authors:  Wei-Fu Lai; Yen-Po Chin; Chih-Wei Liu; Chang-Youh Tsai
Journal:  BMJ Case Rep       Date:  2017-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.